{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:31:56Z","timestamp":1790184716789,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:00:00Z","timestamp":1482451200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Pharmacybrands\/ProPharma\/Pharmacy Guild\/Pharmaceutical Society of NZ"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11096-016-0415-1","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T05:42:02Z","timestamp":1482558122000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0366-0357","authenticated-orcid":false,"given":"Natalie J.","family":"Gauld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene S. L.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary B.","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Buetow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"415_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007182.pub2","author":"A Zalmanovici Trestioreanu","year":"2010","unstructured":"Zalmanovici Trestioreanu A, Green H, Paul M, Yaphe J, Leibovici L. Antimicrobial agents for treating uncomplicated urinary tract infection in women. Cochrane Database Syst Rev. 2010. doi: 10.1002\/14651858.CD007182.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"415_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/AOG.0b013e318169f6ef","volume":"111","author":"American College of Obstetricians and Gynecologists","year":"2008","unstructured":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111(3):785\u201394.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"415_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkl502","volume":"59","author":"D Reeves","year":"2007","unstructured":"Reeves D. The 2005 Garrod Lecture: the changing access of patients to antibiotics\u2013for better or worse? J Antimicrob Chemother. 2007;59(3):333\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"415_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3441","author":"K Knox","year":"2015","unstructured":"Knox K. Women should be able to get antibiotics for urinary tract infection without a prescription. BMJ. 2015;. doi: 10.1136\/bmj.h3441 .","journal-title":"BMJ"},{"issue":"6","key":"415_CR5","first-page":"115","volume":"3","author":"N Gauld","year":"2012","unstructured":"Gauld N. Improving access to urinary tract infection treatment: the reclassification of trimethoprim. SelfCare J. 2012;3(6):115\u201320.","journal-title":"SelfCare J"},{"key":"415_CR6","unstructured":"Classification of Medicines. New Zealand Gazette. 2012;4347:2281."},{"key":"415_CR7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11096-016-0388-0","volume":"38","author":"R Braund","year":"2016","unstructured":"Braund R, Henderson E, McNab E, Sarten R, Wallace E, Gauld N. Pharmacist-only trimethoprim: pharmacist satisfaction on their training and the impact on their practice. Int J Clin Pharm. 2016;38:1357\u201361.","journal-title":"Int J Clin Pharm"},{"key":"415_CR8","unstructured":"Antibiotics: choices for common infections. Best Practice J. 2011;35 Suppl, April."},{"key":"415_CR9","unstructured":"Antibiotics: choices for common infections. In: Best practice journal. Best Practice Advocacy Centre (BPAC). 2013. http:\/\/www.bpac.org.nz\/Supplement\/2013\/July\/docs\/Antibioitcs_guide_2013.pdf . Accessed 2 Dec 2016."},{"issue":"609","key":"415_CR10","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.3399\/bjgp13X665206","volume":"63","author":"JL Booth","year":"2013","unstructured":"Booth JL, Mullen AB, Thomson DAM, Johnstone C, Galbraith SJ, Bryson SM, et al. Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study. Br J Gen Pract. 2013;63(609):e244\u20139. doi: 10.3399\/bjgp13X665206 .","journal-title":"Br J Gen Pract"},{"key":"415_CR11","unstructured":"Trimethoprim and nitrofurantoin POM-to-P switches abandoned. Pharm J. 2010;284:417. http:\/\/www.pharmaceutical-journal.com\/news-and-analysis\/news\/trimethoprim-and-nitrofurantoin-pom-to-pswitches-abandoned\/11008849.article ."},{"key":"415_CR12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/dkp305","volume":"64","author":"MS Dryden","year":"2009","unstructured":"Dryden MS, Cook J, Davey P. Antibiotic stewardship\u2014more education and regulation not more availability? J Antimicrob Chemother. 2009;64:885\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"415_CR13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jac\/dkg127","volume":"51","author":"A Upton","year":"2003","unstructured":"Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother. 2003;51(3):613\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"415_CR14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3399\/bjgp09X473132","volume":"59","author":"H Davis","year":"2009","unstructured":"Davis H, Mant D, Scott C, Lasserson D, Rose PW. Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis. Br J Gen Pract. 2009;59:897\u2013900.","journal-title":"Br J Gen Pract"},{"key":"415_CR15","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/jac\/dks337","volume":"67","author":"NJ Gauld","year":"2012","unstructured":"Gauld NJ, Jennings LC, Frampton C, Huang QS. Five years of non-prescription oseltamivir: effects on resistance, immunization and stock-piling. J Antimicrob Chemother. 2012;67:2949\u201356. doi: 10.1093\/jac\/dks337 .","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"415_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/ijpp.12200","volume":"24","author":"JP Shaw","year":"2016","unstructured":"Shaw JP, Gauld N, Kelly F. Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand. Int J Pharm Pract. 2016;24(1):6\u201312. doi: 10.1111\/ijpp.12200 .","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"415_CR17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1345\/aph.1P514","volume":"45","author":"CR Schneider","year":"2011","unstructured":"Schneider CR, Everett AW, Geelhoed E, Kendall PA, Murray K, Garnett P, et al. Provision of primary care to patients with chronic cough in the community pharmacy setting. Ann Pharmacother. 2011;45(3):402\u20138.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"415_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/qshc.2005.014720","volume":"15","author":"MC Watson","year":"2006","unstructured":"Watson MC, Bond CM, Grimshaw J, Johnston M. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care. 2006;15(1):53\u20137.","journal-title":"Qual Saf Health Care"},{"issue":"11","key":"415_CR19","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1345\/aph.1L121","volume":"43","author":"FS Kelly","year":"2009","unstructured":"Kelly FS, Williams KA, Benrimoj SI. Does advice from pharmacy staff vary according to the nonprescription medicine requested? Ann Pharmacother. 2009;43(11):1877\u201386.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"415_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11096-007-9187-y","volume":"30","author":"AI Wertheimer","year":"2008","unstructured":"Wertheimer AI, Serradell J. A discussion paper on self-care and its implications for pharmacists. Pharm World Sci. 2008;30(4):309\u201315. doi: 10.1007\/s11096-007-9187-y .","journal-title":"Pharm World Sci"},{"issue":"2","key":"415_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.healthpol.2005.07.001","volume":"77","author":"MH V\u00e4\u00e4n\u00e4nen","year":"2006","unstructured":"V\u00e4\u00e4n\u00e4nen MH, Pietil\u00e4 K, Airaksinen M. Self-medication with antibiotics\u2014does it really happen in Europe? Health Policy. 2006;77(2):166\u201371. doi: 10.1016\/j.healthpol.2005.07.001 .","journal-title":"Health Policy"},{"issue":"1394","key":"415_CR22","first-page":"72","volume":"127","author":"MG Thomas","year":"2014","unstructured":"Thomas MG, Smith AJ, Tilyard MW. Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand. NZ Med J. 2014;127(1394):72\u201384.","journal-title":"NZ Med J"},{"issue":"1437","key":"415_CR23","first-page":"55","volume":"129","author":"N Gauld","year":"2016","unstructured":"Gauld N, Zeng I, Ikram R, Thomas M, Buetow S. Treatment of uncomplicated cystitis: analysis of prescribing in New Zealand. NZ Med J. 2016;129(1437):55\u201363.","journal-title":"NZ Med J"},{"key":"415_CR24","first-page":"535","volume":"280","author":"R Finch","year":"2008","unstructured":"Finch R, Cooke J, Charani E. Will switching lead to increased resistance? (letter). Pharm J. 2008;280:535.","journal-title":"Pharm J"},{"key":"415_CR25","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/jac\/dkr370","volume":"66","author":"M Dryden","year":"2011","unstructured":"Dryden M, Johnson AP, Ashiru-Oredope D, Sharland M. Using antibiotics responsibly: right drug, right time, right dose, right duration. J Antimicrob Chemother. 2011;66:2441\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"415_CR26","unstructured":"Norfloxacin\u2014restriction change reminder. Pharmaceutical Management Agency, Wellington, New Zealand. 2014. http:\/\/www.pharmac.health.nz\/news\/notification-2014-05-16-norfloxacin\/ . Accessed 2 Dec 2016."},{"issue":"3","key":"415_CR27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.emc.2011.04.001","volume":"29","author":"DR Lane","year":"2011","unstructured":"Lane DR, Takhar SS. Diagnosis and management of urinary tract infection and pyelonephritis. Emerg Med Clin North Am. 2011;29(3):539\u201352.","journal-title":"Emerg Med Clin North Am"},{"issue":"1","key":"415_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/clinids\/22.1.91","volume":"22","author":"R Ik\u00e4heimo","year":"1996","unstructured":"Ik\u00e4heimo R, Siitonen A, Heiskanen T, K\u00e4rkk\u00e4inen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22(1):91\u20139.","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-016-0415-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:40:15Z","timestamp":1498358415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-016-0415-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s11096-016-0415-1","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}